MGTX

8.0001.72%
AF

Alexandria Forbes

CEO, President & Director

Dr. Alexandria Forbes, Ph.D. serves as the Chief Executive Officer, Director and President at MeiraGTx Holdings plc (formerly known as MeiraGTx Limited) since March 2015. Prior to joining MeiraGTx, Dr. Forbes served as Senior Vice President of Strategic Operations and Chief Commercial Officer at Kadmon from 2013 to 2015 and served as its Director until May 25, 2018. She served as Managing Director of Sivik Global Healthcare, LLC. She served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015 and served as its Director until June 2018. She worked at Meadowvale Asset Management since January 2010 until June 2012. She worked as a healthcare investor at Sivik/Argus Partners. At Sivik Partners Dr. Forbes was responsible for investments in biotechnology, specialty pharmaceuticals and diagnostics, and was portfolio manager for the Sivik Global Life Science Fund, a long-biased public markets fund investing in biotechnology companies globally. Before entering the hedge fund industry, Dr. Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center from March 1997 to September 2000. Prior to this, Dr. Forbes was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University. She is also a member of the Emerging Companies Section and Health Section Governing Boards of the Biotechnology Innovation Organization (BIO). She serves as a Trustee and Director of the Hilary and Galen Weston Foundation, the European arm of the Weston Brain Institute. Dr. Forbes received an M.A. in Natural Sciences from Cambridge University and a Ph.D. in Molecular Genetics from Oxford University.

Positions